ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
4 hedge funds and large institutions have $1.08M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
2
Calls
$2K
Puts
$258K
Net Calls
-$256K
Net Calls Change
-$256K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$519K |
| 2 |
Morgan Stanley
New York
|
$145K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$72K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
| 2 |
Jane Street
New York
|
$0 |
| 3 |
VF
Virtu Financial
New York
|
$339K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $519K | +$519K | +23,731 | New |
|
|
VF
2
Virtu Financial
New York
| $339K | -$289K | -13,202 | -46% |
|
|
3
Morgan Stanley
New York
| $145K | +$145K | +6,578 | +82,225% |
|
|
4
UBS Group
Zurich,
Switzerland
| $72K | +$72K | +3,273 | New |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$360K | -27,954 | Closed |
|
|
6
Jane Street
New York
| – | -$328K | -25,591 | Closed |
|